Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy

Circ Genom Precis Med. 2024 Feb;17(1):e004028. doi: 10.1161/CIRCGEN.122.004028. Epub 2023 Dec 13.

Affiliations

¹ Invitae Corporation, San Francisco, CA (A.M., C.M., T.E.C., K.E.H., R.L.N., E.R., S. Rojahn, M.V., E.D.E.).
² Optum Labs, Eden Prairie, MN (S. Ren, E.S., T.H., J.M.).

PMID: 38088168
DOI: 10.1161/CIRCGEN.122.004028

No abstract available

Keywords: cardiomyopathies; genetic testing; guideline adherence; outcome assessment, health care; utilization review.

MeSH terms

Cardiomyopathies* / diagnosis
Cardiomyopathies* / genetics
Genetic Testing
Humans